XTRA:BASChemicals
BASF (XTRA:BAS) Wins FDA Clearance, Is The Upside Already Priced In?
BASF (XTRA:BAS) has gained FDA clearance to market its Bemotrizinol UV filter, sold as Tinosorb S, in the U.S. This move opens access to an 18 month co exclusive sunscreen window.
See our latest analysis for BASF.
The FDA clearance comes as BASF trades at €51.15, with a 1 day share price return of 1.95% and a 30 day share price return of 5.37%. The 1 year total shareholder return of 15.56% points to steadier progress over a longer horizon.
If this kind of product driven catalyst interests...